Can GDMT Be Safely Stopped After AF Ablation? - Report - MDSpire
Advertisement
Can GDMT Be Safely Stopped After AF Ablation?
Three of 23 patients experienced heart failure deterioration following medication withdrawal, while adverse drug events occurred only among patients who continued therapy.
Clinical Report: Can GDMT Be Safely Stopped After AF Ablation?
Overview
This study investigates the safety of discontinuing guideline-directed medical therapy (GDMT) in patients with atrial fibrillation (AF) after successful catheter ablation. Heart failure deterioration was observed in a subset of patients who stopped GDMT.
Background
Atrial fibrillation is a prevalent condition that can lead to heart failure and other complications. Catheter ablation has emerged as a treatment option that may restore cardiac function in patients with AF-mediated cardiomyopathy.
Data Highlights
Group
Heart Failure Deterioration
NT-proBNP Levels
Adverse Events
GDMT Withdrawal
3 of 23 (13%)
Less decline
0
GDMT Continuation
0 of 24 (0%)
More decline
5 of 24 (21%)
Key Findings
Heart failure deterioration occurred in 13% of patients who withdrew GDMT.
No heart failure deterioration was observed in the GDMT continuation group.
NT-proBNP levels declined more significantly in patients who continued GDMT.
Adverse drug events were reported only in the GDMT continuation group (21%).
Atrial tachyarrhythmia recurrence rates were equal in both groups (13%).
Clinical Implications
Continuous monitoring and assessment of cardiac function are essential in this patient population.
Conclusion
Further larger studies with longer follow-up are needed to determine whether GDMT can be safely discontinued in this population.
